What is SI's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.38B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for SI?

P/E (TTM) is n/a and 52-week range is $10.92 to $24.59 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s SI figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for SI?

The company profile lists revenue (TTM) near $48M, net income (TTM) near $2M, EPS (TTM) near $-0.56 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Shoulder Innovations Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Grand Rapids, Michigan, US, 20.7M shares outstanding, ISIN US82537J1088 when available from company profile and filing metadata.

Shoulder Innovations Inc (SI) Stock Analysis & Quote

Shoulder Innovations Inc

$SI

Health Care · Health Care Equipment & Supplies

Run Scenarios

$18.13

+1.34%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Shoulder Innovations, Inc. manufactures medical devices. The company is headquartered in Grand Rapids, Michigan and currently employs 72 full-time employees. The company went IPO on 2025-07-31. The firm offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.

Employees

Website

shoulderinnovations.com/

IPO

2025-07-31

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)